Florida private school says it will not employ teachers who get the COVID-19 vaccine

A private school founded by an anti-vaccination activist in South Florida has warned teachers and staff against taking the COVID-19 vaccine, saying it will not employ anyone who has received the shot.

FDA to scrutinize approvals on cancer drugs that have failed to show they extend or improve life

The U.S. Food and Drug Administration convenes Tuesday for the first meeting in a decade to consider clawing back approvals from several cancer drugs that have failed to show they extend or improve life.

Vice President Harris tells UN it's time now to prepare for next pandemic

Vice President Kamala Harris is making the case before United Nations members that now is the time for global leaders to begin working on how they will respond to the next global pandemic.

Biden signs law designating sesame as major food allergen, requires labeling on packaged foods

President Joe Biden has signed into law a bill that makes sesame the ninth major allergen in the United States, requiring food makers to clearly label packaging by January 2023.

EU launches legal action against COVID-19 vaccine maker AstraZeneca over dose shortage

The European Commission says it’s launched legal action against the COVID-19 vaccine maker AstraZeneca in regards to an untimely delivery of millions of doses.

Fauci expects CDC to revise mask guidelines, says COVID-19 transmission risk outdoors is ‘really low’

Dr. Anthony Fauci, director of the National Institutes of Allergy and Infectious Diseases, said Sunday he expects the CDC to revise its guidelines after acknowledging that the risk of COVID-19 transmission in an outdoor setting is “really low.”

Johnson & Johnson vaccine: CDC lifts suspension amid blood clot concerns

Advisers to the CDC said Friday that it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.

Moderna CEO: COVID-19 vaccine surplus possible in 2022

Moderna Inc. said Friday that the company is on track to produce 1 billion doses of its COVID-19 vaccine this year, and there could be an oversupply in 2022.